Similarly, Cornec et al. reviewed multitargeted imidazoles as potential therapeutic leads for AD and other neurodegenerative diseases and outlined the importance of COX and LOX pathway modulation in improved AD treatment [17]. The gene discussed is LOX; the disease is neurodegenerative disease.